EUVIMEDEUVIMED entdecken
Crossref

2‐Hydroxy‐4‐benzyloxylimine Resveratrol Derivatives as Potential Multifunctional Agents for the Treatment of Parkinson's Disease

Zhongcheng Cao iD, Tianlong Zhang, Xianwu Fu, Xingyue Wang, Qian Xia, Lei Zhong, Jiang Zhu

ChemMedChem · 2023

DOI: 10.1002/cmdc.202200629 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2023. Verfasst von Zhongcheng Cao und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, North Sichuan Medical College, Nanchong, 637000, P. R. China. Hauptthemen laut MEDLINE: Parkinson Disease, Neuroprotective Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of 2‐hydroxy‐4‐benzyloxylimine resveratrol derivatives was designed, synthesized and evaluated as multifunctional agents for the treatment of Parkinson's disease. The results revealed that most derivatives possessed good multifunctional activities. Among them, representative compound ( E )‐5‐[(4‐fluorobenzyl)oxy]‐2‐{[(4‐hydroxyphenyl)imino]methyl}phenol ( 7 h ) exhibited excellent MAO‐B inhibition (IC 50 =8.43×10 −3 μM) and high antioxidant activity (ORAC=3.45 Trolox equivalent). Additionally, 7 h displayed good metal chelating ability, appropriate blood–brain barrier (BBB) permeability, significant neuroprotective effect, and great anti‐neuroinflammatory activity. Furthermore, 7 h can also ameliorate 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced Parkinson's disease symptoms in mice. Therefore, compound 7 h was found to be a promising candidate for further development against PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseNeuroprotective AgentsMiceAnimalsResveratrolMonoamine Oxidase InhibitorsAntioxidantsChelating AgentsMonoamine Oxidase

Stichwörter der Autor:innen

2-hydroxy-4-benzyloxyimine resveratrol derivativesMAO-B inhibitorsParkinson's diseaseantioxidantsmultifunctional anti-PD agents

Substanzen

ResveratrolMonoamine Oxidase InhibitorsAntioxidantsChelating AgentsMonoamine OxidaseNeuroprotective Agents

Autor:innen und Institutionen

  • School of Pharmacy, North Sichuan Medical College, Nanchong, 637000, P. R. China.
  • Sichuan Key Laboratory of Medical Imaging, Nanchong, 637000, P. R. China.
  • Sichuan Key Laboratory of Medical Imaging, School of Pharmacy and Nanchong Key laboratory of MRI Contrast Agent, North Sichuan Medical College, Nanchong, 637000, P. R. China.

ORCID-Profile: Zhongcheng Cao

Zitieren

APA

Cao, Z., Zhang, T., Fu, X., Wang, X., Xia, Q., Zhong, L., & Zhu, J. (2023). 2‐Hydroxy‐4‐benzyloxylimine Resveratrol Derivatives as Potential Multifunctional Agents for the Treatment of Parkinson's Disease. ChemMedChem. https://doi.org/10.1002/cmdc.202200629

Vancouver

Cao Z, Zhang T, Fu X, Wang X, Xia Q, Zhong L, et al. 2‐Hydroxy‐4‐benzyloxylimine Resveratrol Derivatives as Potential Multifunctional Agents for the Treatment of Parkinson's Disease. ChemMedChem. 2023. doi:10.1002/cmdc.202200629

BibTeX
@article{Cao2023,
  author = {Cao, Zhongcheng and Zhang, Tianlong and Fu, Xianwu and Wang, Xingyue and Xia, Qian and Zhong, Lei and Zhu, Jiang},
  title = {2‐Hydroxy‐4‐benzyloxylimine Resveratrol Derivatives as Potential Multifunctional Agents for the Treatment of Parkinson's Disease},
  journal = {ChemMedChem},
  year = {2023},
  doi = {10.1002/cmdc.202200629}
}
Kostenlos starten →